New combo therapy may boost IVF success for women with painful uterine condition

NCT ID NCT06913075

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding letrozole to standard GnRH agonist therapy improves pregnancy rates in women with adenomyosis undergoing frozen embryo transfer. About 700 participants will be randomly assigned to one of two groups. The main goal is to see if more women have a healthy pregnancy at 12 weeks with the combination treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADENOMYOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Indira IVF Pvt Hospital

    Udaipur, Rajasthan, 313001, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.